For patienter som initielt ikke fik reperfusion, var incidensen for alvorlig blødning 1, 2% for fondaparinux versus 1, 5% i kontrolgruppen.
In patients given a thrombolytic, severe haemorrhage occurred in 1.3% of the fondaparinux patients and in 2.0% of controls.